$OGEN
ORAGENICS INC Stock $ogen

$ogen Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223027838 Filed on August 11, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$7.466K	$13.16K	$30.39K
YoY Change	-91.32%	-56.69%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.330M	$1.116M	$1.044M
YoY Change	9.46%	6.84%	-23.79%
% of Gross Profit
Research & Development	$769.4K	$2.007M	$3.033M
YoY Change	-72.76%	-33.84%	22.92%
% of Gross Profit
Depreciation & Amortization	$10.00K	$11.31K	$10.38K
YoY Change	-21.51%	8.96%	-16.63%
% of Gross Profit
Operating Expenses	$2.102M	$3.122M	$4.078M
YoY Change	-47.97%	-23.42%	6.24%
Operating Profit	-$2.094M	-$3.109M	-$3.604M
YoY Change	-47.02%	-13.74%
Interest Expense	$14.17K	$843.00	$14.55K
YoY Change	171.04%	-94.21%	-37.34%
% of Operating Profit
Other Income/Expense, Net	$81.56K	$58.73K	-$120.00
YoY Change	127.08%	-49043.33%
Pretax Income	-$2.013M	-$3.051M	-$4.033M
YoY Change	-48.62%	-24.35%	5.7%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$2.013M	-$3.051M	-$4.033M
YoY Change	-48.62%	-24.35%	5.7%
Net Earnings / Revenue	-26960.69%	-23175.46%	-13269.79%
Basic Earnings Per Share	-$0.85	-$1.51	-$1.85
Diluted Earnings Per Share	-$0.85	-$1.51	-$34.65K
COMMON SHARES
Basic Shares Outstanding	2.539M shares	2.025M shares	1.940M shares
Diluted Shares Outstanding	2.356M shares	2.025M shares	1.940M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.770M	$6.474M	$17.87M
YoY Change	-58.64%	-63.77%	-48.32%
Cash & Equivalents	$5.767M	$6.474M	$17.87M
Short-Term Investments
Other Short-Term Assets	$2.010M	$1.612M	$102.5K
YoY Change	257.68%	1472.54%	17.92%
Inventory
Prepaid Expenses		$1.600M
Receivables
Other Receivables	$35.10K	$13.16K
Total Short-Term Assets	$7.814M	$8.099M	$17.97M
YoY Change	-46.16%	-54.93%	-48.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$52.40K	$98.46K	$495.1K
YoY Change	-60.42%	-80.12%	-15.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.00K	$17.94K
YoY Change
Total Long-Term Assets	$85.34K	$365.7K	$495.1K
YoY Change	-83.83%	-26.15%	-15.48%
TOTAL ASSETS
Total Short-Term Assets	$7.814M	$8.099M	$17.97M
Total Long-Term Assets	$85.34K	$365.7K	$495.1K
Total Assets	$7.899M	$8.464M	$18.47M
YoY Change	-47.48%	-54.16%	-47.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$810.0K	$590.6K	$1.280M
YoY Change	-7.01%	-53.85%	-33.71%
Accrued Expenses	$45.28K	$334.4K	$180.8K
YoY Change	-77.58%	84.96%	-2.62%
Deferred Revenue
YoY Change
Short-Term Debt	$490.0K	$0.00	$0.00
YoY Change	15.32%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.402M	$1.141M	$1.460M
YoY Change	-6.4%	-21.85%	-30.98%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$65.75K	$217.4K
YoY Change	-100.0%	-69.75%	-45.41%
Total Long-Term Liabilities		$65.75K	$217.4K
YoY Change		-69.75%	-45.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.402M	$1.141M	$1.460M
Total Long-Term Liabilities		$65.75K	$217.4K
Total Liabilities	$1.402M	$1.207M	$1.678M
YoY Change	-17.65%	-28.06%	-33.27%
SHAREHOLDERS EQUITY
Retained Earnings	-$193.5M	-$191.5M
YoY Change	4.43%
Common Stock	$2.549K	$2.025K
YoY Change	-97.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.497M	$7.257M	$16.79M
YoY Change
Total Liabilities & Shareholders Equity	$7.899M	$8.464M	$18.47M
YoY Change	-47.48%	-54.16%	-47.61%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$2.013M	-$3.051M	-$4.033M
YoY Change	-48.62%	-24.35%	5.7%
Depreciation, Depletion And Amortization	$10.00K	$11.31K	$10.38K
YoY Change	-21.51%	8.96%	-16.63%
Cash From Operating Activities	-$1.500M	-$2.577M	-$3.383M
YoY Change	-60.27%	-23.83%	62.76%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$60.00K	$0.00	$0.00
YoY Change
Cash From Investing Activities	$60.00K	$0.00	$0.00
YoY Change	-262.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	730.0K	-107.9K	-122.2K
YoY Change	-805.31%	-11.7%	-180.24%
NET CHANGE
Cash From Operating Activities	-1.500M	-2.577M	-3.383M
Cash From Investing Activities	60.00K	0.000	0.000
Cash From Financing Activities	730.0K	-107.9K	-122.2K
Net Change In Cash	-710.0K	-2.685M	-3.505M
YoY Change	-81.87%	-23.41%	81.97%
FREE CASH FLOW
Cash From Operating Activities	-$1.500M	-$2.577M	-$3.383M
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	-$1.500M	-$2.577M	-$3.383M
YoY Change	-59.88%	-23.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001174940
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2023Q2	OGEN	Local Business Tax LocalBusinessTax		usd
	OGEN	Local Business Tax LocalBusinessTax		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	OGEN	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets		usd
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits		usd
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent		usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2022Q4	OGEN	Prepaid Financing Costs PrepaidFinancingCosts		usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent		usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo		usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-32188
	dei	Entity Registrant Name EntityRegistrantName	ORAGENICS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	59-3410522
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4902 Eisenhower Blvd.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 125
	dei	Entity Address City Or Town EntityAddressCityOrTown	Tampa
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33634
	dei	City Area Code CityAreaCode	813
	dei	Local Phone Number LocalPhoneNumber	286-7900
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	OGEN
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2539385	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6473822	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11426785	usd
CY2023Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	13163	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1611849	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2844798	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	8098834	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	14271583	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	98456	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	121062	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	249256	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	347440	usd
CY2023Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	17940	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	17940	usd
CY2023Q2	us-gaap	Assets Assets	8464486	usd
CY2022Q4	us-gaap	Assets Assets	14758025	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	951019	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1124197	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	267640	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	190242	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	204447	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1141261	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1596284	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	65752	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	152439	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	65752	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	152439	usd
CY2023Q2	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2022Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	1592723	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	1592723	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4166666	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4166666	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2024657	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2024657	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2024657	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2024657	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	2025	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2025	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	197120665	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	196977071	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-191457940	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-185562517	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	7257473	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13009302	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8464486	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14758025	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13163	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30391	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	30187	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	45474	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2006696	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2590032	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3679272	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5883693	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1115785	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1044334	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2365048	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2375883	usd
CY2022Q2	OGEN	Local Business Tax LocalBusinessTax	-490	usd
	OGEN	Local Business Tax LocalBusinessTax	-980	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	3122481	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	3634856	usd
	us-gaap	Operating Expenses OperatingExpenses	6044320	usd
	us-gaap	Operating Expenses OperatingExpenses	8260556	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3109318	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3604465	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6014133	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8215082	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	58954	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	15369	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	121155	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	27275	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	843	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	816	usd
	us-gaap	Interest Expense InterestExpense	4190	usd
	us-gaap	Interest Expense InterestExpense	4062	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	621	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	369	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1745	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11333	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	58732	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14922	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	118710	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	34546	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3050586	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3589543	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5895423	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8180536	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3050586	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-3589543	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5895423	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8180536	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.51
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.51
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.85
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.85
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.91
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.91
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.22
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-75047	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	267640	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	303416	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-267640	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-303416	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2024766	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2024766	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2024766	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1939913	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1939913	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1939913	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2024766	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2024766	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2024766	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1939913	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1939913	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1939913	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	13009302	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	79966	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2844837	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	10244431	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	63628	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-3050586	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	7257473	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	26486199	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	90247	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4590993	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	21985453	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	21985453	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	278988	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-3589543	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	18674898	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	18674898	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5895423	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8180536	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22606	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18847	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	10964	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	143594	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	369235	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	13163	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-6987	usd
	OGEN	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	-98184	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1232949	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1555350	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-274070	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	332024	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4685323	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9019757	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	12000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	87047	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4952963	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9398220	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11426785	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	27265703	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6473822	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17867483	usd
	us-gaap	Interest Paid Net InterestPaidNet	3347	usd
	us-gaap	Interest Paid Net InterestPaidNet	4062	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5895423	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4685323	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-191457940	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	98456	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	121062	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11303	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10379	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22606	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18847	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	372989	usd
CY2023Q2	OGEN	Prepaid Financing Costs PrepaidFinancingCosts	75000	usd
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	25000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zFD5wuxDQuO7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_867_zyt2sH3TQ6ij">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. The principal area of estimation reflected in the consolidated financial statements are estimates for research and development expenses and related prepaid and accrued expenses, which are based on the percentage of completion of the Company’s contracts with Contract Research Organizations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84D_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zDlb8wTXnqtf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_865_zPMQ94CUwJ95">Reclassification</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. Adjustments to the Consolidated Balance Sheet and Consolidated Statement of Cash Flows for the six-month period ended June 30, 2022 were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Deposits of $<span id="xdx_902_eus-gaap--DepositsAssetsNoncurrent_iI_c20220630__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zPyLUcHGM0Ja" title="Deposits">17,940</span> were reclassified from Prepaid Expenses and other current assets to Other Assets.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Changes in Operating Lease Right of Use Assets of $<span id="xdx_903_ecustom--IncreaseDecreaseInOperatingLeaseRightOfUseAssets_c20220101__20220630__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zHE4TiFK5pQ5" title="Changes in operating lease right of use assets">45,921</span> was reclassified from Accounts Payable and Accrued Expenses into its own account.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Changes in Operating Lease Liabilities of <span id="xdx_90E_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_c20220101__20220630__srt--RestatementAxis__srt--RevisionOfPriorPeriodReclassificationAdjustmentMember_zHd0zn9sY6A" title="Changes in operating lease liabilities">($47,327)</span> was reclassified from Accounts Payable and Accrued Expenses into its own account.</span> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p>
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1611849	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2844798	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zHYNLRpXYho1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_86C_zY2Ni8w5v4ba">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company maintains cash accounts in commercial banks, which may, at times, exceed federally insured limits. The Company has not experienced any losses in such accounts. The Company believes there is a minimal credit risk on cash and cash equivalents. Cash and cash equivalents could be adversely impacted, including the loss of uninsured deposits and other uninsured financial assets, if one or more of the financial institutions in which the Company holds its cash or cash equivalents fails or is subject to other adverse conditions in the financial or credit markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p>
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1484301	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1484301	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1385845	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1363239	usd
CY2023Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	590576	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	246690	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	334441	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	812861	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	31101	usd
CY2023Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	26002	usd
CY2022Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	33545	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	951019	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1124197	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	267640	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	267640	usd
CY2023Q2	OGEN	Prepaid Research And Development Expense PrepaidResearchAndDevelopmentExpense	1455456	usd
CY2022Q4	OGEN	Prepaid Research And Development Expense PrepaidResearchAndDevelopmentExpense	2471809	usd
CY2023Q2	us-gaap	Prepaid Insurance PrepaidInsurance	56393	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1600000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2800000	usd
CY2022Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	reverse stock split of our common stock by a ratio of one for sixty
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2023Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	260995	shares
CY2023Q2	OGEN	Class Of Warrant Or Right Outstanding Exercisable ClassOfWarrantOrRightOutstandingExercisable	260995	shares
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	63628	usd
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	278988	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	143594	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	369235	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	118874	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.040	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.430	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M15D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y8M19D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0577	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0578	pure
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	109690	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	156605	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	266295	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	10301	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	255994	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	116098	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	114259	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1965	usd
	us-gaap	Lease Cost LeaseCost	116098	usd
	us-gaap	Lease Cost LeaseCost	116224	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	118807	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	117350	usd

Files In Submission

Name	View Source	Status
0001493152-23-027838-index-headers.html	Edgar Link	pending
0001493152-23-027838-index.html	Edgar Link	pending
0001493152-23-027838.txt	Edgar Link	pending
0001493152-23-027838-xbrl.zip	Edgar Link	pending
ex10-6.htm	Edgar Link	pending
ex10-6_001.jpg	Edgar Link	pending
ex10-6_002.jpg	Edgar Link	pending
ex10-6_003.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ogen-20230630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ogen-20230630_cal.xml	Edgar Link	unprocessable
ogen-20230630_lab.xml	Edgar Link	unprocessable
ogen-20230630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ogen-20230630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OGEN
ORAGENICS INC Stock $ogen

2023 Q3 Form 10-Q Financial Statement

#000149315223027838 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OGEN ORAGENICS INC Stock $ogen

2023 Q3 Form 10-Q Financial Statement

#000149315223027838 Filed on August 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OGEN
ORAGENICS INC Stock $ogen